Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CINACALCET for Hyperparathyroidism secondary: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15,990 adverse event reports in the FDA FAERS database where CINACALCET was used for Hyperparathyroidism secondary.

Most Reported Side Effects for CINACALCET

Side Effect Reports % Deaths Hosp.
Drug dose omission 8,683 20.3% 1 378
Hospitalisation 6,997 16.4% 62 6,956
Laboratory test abnormal 4,210 9.9% 0 31
Off label use 2,655 6.2% 108 180
Intentional product misuse 2,092 4.9% 1 78
Nausea 1,857 4.4% 26 153
Death 1,652 3.9% 1,646 106
Malaise 1,451 3.4% 8 246
Adverse drug reaction 1,447 3.4% 8 13
Vomiting 1,270 3.0% 38 164
Diarrhoea 845 2.0% 27 98
Decreased appetite 750 1.8% 24 73
Abdominal discomfort 697 1.6% 2 28
Drug ineffective 618 1.5% 31 127
Muscle spasms 504 1.2% 3 21

Other Indications for CINACALCET

Product used for unknown indication (23,467) Hyperparathyroidism (704) Hypercalcaemia (594) Hyperparathyroidism primary (510) Chronic kidney disease (222) End stage renal disease (195) Calciphylaxis (85) Blood parathyroid hormone increased (81) Hyperparathyroidism tertiary (79) Blood calcium increased (67)

Other Drugs Used for Hyperparathyroidism secondary

PARICALCITOL (2,607) ETELCALCETIDE (1,407) CALCIFEDIOL (352) SENSIPAR (248) ZEMPLAR (61) CALCITRIOL (50) DOXERCALCIFEROL (34) DENOSUMAB (22) MIMPARA (22) EVOCALCET (18)

Related Pages

CINACALCET Full Profile All Hyperparathyroidism secondary Drugs CINACALCET Demographics CINACALCET Timeline